Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma

Hum Gene Ther. 1994 Sep;5(9):1161-8. doi: 10.1089/hum.1994.5.9-1161.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Carcinoma / pathology
  • Carcinoma / therapy*
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / therapy*
  • Cells, Cultured
  • Clinical Protocols
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy*
  • Female
  • Gene Transfer Techniques*
  • Genetic Therapy* / adverse effects
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Interferon-gamma / pharmacology
  • Interleukin-1 / pharmacology
  • Interleukin-2 / pharmacology
  • Interleukin-7 / adverse effects
  • Interleukin-7 / biosynthesis
  • Interleukin-7 / genetics*
  • Kidney Neoplasms / pathology
  • Kidney Neoplasms / therapy*
  • Killer Cells, Lymphokine-Activated / drug effects
  • Killer Cells, Lymphokine-Activated / metabolism
  • Killer Cells, Lymphokine-Activated / transplantation*
  • Lymphoma, Non-Hodgkin / pathology
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Melanoma / pathology
  • Melanoma / therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Palliative Care*
  • Recombinant Fusion Proteins / adverse effects
  • Recombinant Fusion Proteins / biosynthesis
  • Salvage Therapy

Substances

  • Interleukin-1
  • Interleukin-2
  • Interleukin-7
  • Recombinant Fusion Proteins
  • Interferon-gamma